Development of an In Vitro Model of SARS-CoV-Induced Acute Lung Injury for Studying New Therapeutic Approaches.

MLA

Shevtsova, Yulia A., et al. “Development of an In Vitro Model of SARS-CoV-Induced Acute Lung Injury for Studying New Therapeutic Approaches.” Antioxidants, vol. 11, no. 10, Oct. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3390/antiox11101910.

APA

Shevtsova, Y. A., Goryunov, K. V., Babenko, V. A., Pevzner, I. B., Vtorushina, V. V., Inviyaeva, E. V., Krechetova, L. V., Zorova, L. D., Plotnikov, E. Y., Zorov, D. B., Sukhikh, G. T., & Silachev, D. N. (2022). Development of an In Vitro Model of SARS-CoV-Induced Acute Lung Injury for Studying New Therapeutic Approaches. Antioxidants, 11(10), N.PAG. https://doi.org/10.3390/antiox11101910

Chicago

Shevtsova, Yulia A., Kirill V. Goryunov, Valentina A. Babenko, Irina B. Pevzner, Valentina V. Vtorushina, Evgeniya V. Inviyaeva, Lyubov V. Krechetova, et al. 2022. “Development of an In Vitro Model of SARS-CoV-Induced Acute Lung Injury for Studying New Therapeutic Approaches.” Antioxidants 11 (10): N.PAG. doi:10.3390/antiox11101910.